Medifast, Inc.
MED
$12.57
$0.171.37%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -36.31% | -35.96% | -36.29% | -37.62% | -39.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.31% | -35.96% | -36.29% | -37.62% | -39.47% |
| Cost of Revenue | -27.12% | -29.93% | -32.98% | -37.39% | -41.14% |
| Gross Profit | -39.56% | -38.11% | -37.47% | -37.70% | -38.85% |
| SG&A Expenses | -34.28% | -32.88% | -37.86% | -36.45% | -31.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.15% | -31.87% | -36.28% | -36.48% | -34.24% |
| Operating Income | -398.25% | -192.40% | -37.29% | -62.07% | -92.36% |
| Income Before Tax | -11.47% | -248.84% | -83.61% | -83.23% | -108.35% |
| Income Tax Expenses | 4,433.45% | 668.51% | -64.50% | -67.13% | -101.43% |
| Earnings from Continuing Operations | -186.19% | -992.54% | -96.61% | -87.60% | -110.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -186.19% | -992.54% | -96.61% | -87.60% | -110.32% |
| EBIT | -398.25% | -192.40% | -37.29% | -62.07% | -92.36% |
| EBITDA | -121.07% | -99.89% | -12.47% | -43.62% | -79.94% |
| EPS Basic | -184.77% | -979.45% | -96.65% | -87.70% | -110.28% |
| Normalized Basic EPS | -321.44% | -138.21% | 12.17% | -51.65% | -94.73% |
| EPS Diluted | -181.48% | -1,049.97% | -98.57% | -88.07% | -110.50% |
| Normalized Diluted EPS | -324.82% | -138.58% | 12.43% | -51.62% | -94.79% |
| Average Basic Shares Outstanding | 0.50% | 0.46% | 0.44% | 0.42% | 0.41% |
| Average Diluted Shares Outstanding | 0.48% | 0.32% | 0.41% | 0.45% | 0.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.85% | -1.03% | -0.69% | -0.96% | -1.04% |